TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 116 filers reported holding TRILLIUM THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $35,000 | +84.2% | 2,000 | 0.0% | 0.01% | +100.0% |
| Q2 2021 | $19,000 | -9.5% | 2,000 | 0.0% | 0.00% | -40.0% |
| Q1 2021 | $21,000 | -27.6% | 2,000 | 0.0% | 0.01% | -28.6% |
| Q4 2020 | $29,000 | +3.6% | 2,000 | 0.0% | 0.01% | -22.2% |
| Q3 2020 | $28,000 | +40.0% | 2,000 | -20.0% | 0.01% | +12.5% |
| Q2 2020 | $20,000 | +100.0% | 2,500 | 0.0% | 0.01% | +60.0% |
| Q1 2020 | $10,000 | – | 2,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|